After India, Innocan Pharma Secures Patent Allowance in Japan for Liposomal CBD Delivery Platform
Israel-based pharmaceutical technology company Innocan Pharma Corporation has announced that its patent for the liposomal delivery platform LPT-CBD has been allowed in Japan and will be officially granted following the completion of administrative process.
Intellectual Property | 16/10/2025 | By Dineshwori | 100
Innovent Signs Agreement with IASO Bio for Cell Therapy
Innovent Biologics, Inc. and IASO Biotechnology have signed an agreement on a series of cooperation, including IASO Bio's purchase from Innovent regarding its relevant right of FUCASO (Equecabtagene Autoleucel) and obtaining license from Innovent regarding the intellectual property related to FUCASO, as well as Innovent's equity investment in IASO Bio.
Intellectual Property | 06/07/2024 | By Aishwarya | 518
Northwest Biotherapeutics Bags Exclusive In-License of Dendritic Cell Technology
Northwest Biotherapeutics has announced an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual property (IP).
Intellectual Property | 18/06/2024 | By Aishwarya | 497
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy